What WEATECHO S.R.L. does

Weatecho S.r.l. is an Italian med-tech spin-off of the Polytechnic University of Bari, founded in 2022 and headquartered in Bari, Puglia. The company develops point-of-care diagnostic support and prevention devices built on a proprietary platform integrating biosensing, microfluidics, nanotechnologies (notably functionalized gold nanoparticles), photonics/plasmonics, and digital/AI-assisted interpretation tools. Its product portfolio comprises three core assets: PEARL, a saliva-based point-of-care solution that semi-quantifies salivary alpha-amylase activity as a biomarker for early Alzheimer's diagnosis, developed under the Regione Puglia TecnoNidi programme; Femtech, a colorimetric gold-nanoparticle biosensor paired with a smartphone app that uses AI/ML for automated result interpretation in at-home vaginal health monitoring; and Flash Bot, an autonomous robot for transporting clinical samples and pharmaceuticals within hospitals and clinics as part of a Hospital 4.0 collaborative robotics ecosystem with Predict S.p.A.

The company targets healthcare providers, hospitals, neurodegenerative disease centers, women's health consumers, and public/private healthcare facilities seeking logistics automation. Its go-to-market combines direct partnerships with clinical institutions (including Panico Hospital and the Centre for Neurodegenerative Diseases) for validation and pathway integration, together with channel partnerships (Predict S.p.A.) for robotics distribution. The business model is hardware-led — revenues are intended to flow from the sale of diagnostic devices and robots — though no commercial pricing has been disclosed and products remain in development and platform-validation phases rather than full commercial launch.

Weatecho is privately held as an Italian S.r.l., led by CEO Lino Renna (a biotech/healthcare-services entrepreneur with 30+ years of experience) and CTO Francesco Dell'Olio (Professor of Electronics at the Polytechnic of Bari and head of its Micro Nano Sensor Group), supported by approximately five additional team members across research, business development, and communications. The company holds ISO 9001:2015 certification for research activities developing software and medical devices in healthcare, and maintains research collaborations with the Polytechnic University of Bari and IIT Genova.

Name

WEATECHO S.R.L.

Legal name

WEATECHO S.r.l.

Website

https://weatecho.com

Company type

Private

Founded year

2022

Operating status

Operating

Short description

Weatecho S.r.l. is an Italian med-tech spin-off of the Polytechnic University of Bari developing non-invasive point-of-care diagnostic devices and healthcare robotics — including a saliva-based Alzheimer's test (PEARL), a women's health colorimetric biosensor (Femtech), and a hospital logistics robot (Flash Bot) — for hospitals, clinics, and at-home users.

Ownership category

akta.pro rank

Product category

Point-of-Care Diagnostic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

akta.pro secondary industries

SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

Keywords

• Point-of-care diagnostics
• Biosensor devices
• Alzheimer's diagnostics
• Women's health devices
• Medical nanotechnology

Headquarters

HQ city

Bari

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Medical Devices: Revenue from development and sale of point-of-care diagnostic devices (PEARL for Alzheimer's, Femtech for vaginal health). Devices designed for clinical care pathways with potential for both institutional (hospital) and consumer (self-testing) deployment.
2. Healthcare Robotics: Revenue from Flash Bot autonomous transport robots for Hospital 4.0 applications, integrated with collaborative robotics ecosystem.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

WEATECHO develops point-of-care diagnostic support and prevention devices, including PEARL (a saliva-based biosensor for early Alzheimer's detection via salivary alpha-amylase biomarker), Femtech (a colorimetric AuNP biosensor for vaginal health monitoring with AI-driven smartphone app interpretation), and Flash Bot (an autonomous robot for transporting clinical samples and pharmaceuticals within hospitals). The portfolio integrates microfluidics, nanotechnologies, photonics/plasmonics, and AI/ML algorithms into accessible, non-invasive diagnostic tools designed for clinical care pathways.

Product overview

WEATECHO S.R.L. is developing a portfolio of advanced medical diagnostic devices focused on early disease detection and health monitoring. The company offers three core products: PEARL (a saliva-based point-of-care biosensor for early Alzheimer's diagnosis), Femtech (a colorimetric biosensor with smartphone app for vaginal health monitoring), and Flash Bot (a hospital logistics robot for autonomous clinical sample and pharmaceutical transport). Both PEARL and Femtech are designed as non-invasive, rapid, accessible point-of-care solutions that complement traditional medical pathways rather than replacing them.

Differentiator

Problem solved

Functional benefit

Products and services

• PEARL A non-invasive point-of-care saliva-based diagnostic solution for early Alzheimer's disease detection. PEARL semi-quantifies salivary alpha-amylase activity as a neurodegenerative biomarker using advanced biosensors, providing a rapid, accessible, low-cost alternative to invasive diagnostic procedures for hospitals, clinics, and neurodegenerative disease centers.
• Femtech An advanced colorimetric biosensor for rapid vaginal health monitoring using functionalized gold nanoparticles (AuNPs) to generate colorimetric signals associated with relevant biomarkers. A companion smartphone app applies AI and machine learning algorithms to interpret results, eliminating subjective reading variability and providing accessible monitoring for women and clinics.
• Flash Bot An autonomous robot for efficient transport of clinical samples and pharmaceuticals within hospitals and clinics, designed for Hospital 4.0 integration and commercialized through the Predict S.p.A. collaborative robotics network.

Quantifiable outcome

• Saliva-based Alzheimer's diagnosis with semi-quantification of salivary alpha-amylase activity
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• Predict S.p.A.coreStrategic or Co-development Partner · 23 January 2026Network agreement to create integrated ecosystem of collaborative robotics for Hospital 4.0. Weatecho contributes Flash Bot robot for autonomous transport of clinical samples and pharmaceuticals. Partnership valid for 24 months, registered with Bari Companies Register. Combined expertise enables transfer of Industry 4.0 standards into healthcare sector.
• Panico Hospital in Tricase (Prof. Giancarlo Logroscino)coreStrategic or Co-development PartnerCollaboration on Alzheimer's topic with Centre for Neurodegenerative Diseases and Brain Ageing. Clinical validation of non-invasive diagnostic approaches, validation of use pathways, and dialogue with specialized expertise in neurodegenerative diseases and brain ageing.
• Polytechnic University of Bari - Micro Nano Sensor GroupcoreStrategic or Co-development PartnerScientific collaboration on biosensing, advanced sensing, photonics, and transfer of research results into application-oriented devices. Francesco Dell'Olio leads the Micro Nano Sensor Group and coordinates Weatecho's scientific and technological strategy.
• Istituto Italiano di Tecnologia (IIT) Genova - Dr. Pierpaolo PompacoreStrategic or Co-development PartnerCollaboration on nanotechnologies and advanced approaches for diagnostics and biofunctionalization of sensing platforms. Joint research activities and technology development for biomedical applications.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• BioFire Diagnostics (bioMérieux): Subsidiary of bioMérieux providing rapid molecular diagnostic systems widely used in clinical settings. Broad incumbent peer to Weatecho's POC diagnostic strategy and clinical validation pathway.
• Quanterix: Public ultra-sensitive biomarker detection platform (Simoa) used for neurodegenerative disease research and diagnostics. Comparable to Weatecho in targeting neurodegenerative biomarker measurement, but operating as a broad tools/services incumbent rather than a dedicated POC device.
• Aethon (ST Robotics): Established US-based provider of autonomous mobile robots for hospital logistics (TUG). Comparable to Weatecho's Flash Bot as the incumbent peer in intra-hospital autonomous transport of clinical samples and pharmaceuticals.
• Abbott i-STAT / Alinity: Global diagnostics incumbent offering point-of-care and laboratory platforms used across hospitals. Comparable to Weatecho as the dominant POC/clinical diagnostic platform peer against which Weatecho's PEARL and Femtech must differentiate.

Emerging players

• QuantuMDx: UK-based developer of rapid, POC molecular diagnostic devices. Comparable to Weatecho as a peer developing compact POC diagnostic hardware for clinical and resource-limited settings.
• Clip Health (formerly Mira): Startup building smartphone-coupled POC diagnostic tests for health screening. Comparable to Weatecho's Femtech for the smartphone-AI colorimetric consumer/home-testing angle and similar early-stage profile.

Direct peers

• Daye: UK femtech offering at-home vaginal health diagnostics (e.g., STI screening, microbiome testing). Directly comparable to Weatecho's Femtech product targeting vaginal health self-monitoring.
• ADx NeuroSciences: Belgian biomarker assay developer focused on Alzheimer's and neurodegenerative disease diagnostics. Directly comparable to Weatecho's PEARL as a specialized assay developer targeting early Alzheimer's.
• Evvy: US femtech focused on vaginal microbiome testing and women's health diagnostics. Directly comparable to Weatecho's Femtech on target market (women's health self-testing) and biomarker-based assay model.
• C₂N Diagnostics: US diagnostics company with the PrecivityAD blood-based biomarker test for early Alzheimer's detection. Directly comparable to Weatecho's PEARL in clinical intent (early Alzheimer's detection via an accessible biomarker assay).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WEATECHO S.R.L.